Biechele Royce Advisors Amgen Inc Transaction History
Biechele Royce Advisors
- $303 Million
- Q3 2024
A detailed history of Biechele Royce Advisors transactions in Amgen Inc stock. As of the latest transaction made, Biechele Royce Advisors holds 64,848 shares of AMGN stock, worth $19.1 Million. This represents 6.89% of its overall portfolio holdings.
Number of Shares
64,848
Previous 67,072
3.32%
Holding current value
$19.1 Million
Previous $21 Million
0.3%
% of portfolio
6.89%
Previous 7.08%
Shares
28 transactions
Others Institutions Holding AMGN
# of Institutions
3,122Shares Held
410MCall Options Held
7.56MPut Options Held
7.2M-
Vanguard Group Inc Valley Forge, PA52.4MShares$15.4 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$13.6 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.3MShares$8.63 Billion0.39% of portfolio
-
Morgan Stanley New York, NY14.7MShares$4.33 Billion0.35% of portfolio
-
Primecap Management CO Pasadena, CA14.3MShares$4.2 Billion3.44% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $158B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...